- Home
- RNAZ vs YCBD Comparison
RNAZ vs YCBD Comparison
Compare RNAZ & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- YCBD
- Stock Information
- Founded
- RNAZ 2016
- YCBD 2015
- Country
- RNAZ United States
- YCBD United States
- Employees
- RNAZ N/A
- YCBD N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- RNAZ Health Care
- YCBD Health Care
- Exchange
- RNAZ Nasdaq
- YCBD Nasdaq
- Market Cap
- RNAZ 8.7M
- YCBD 7.8M
- IPO Year
- RNAZ 2021
- YCBD N/A
- Fundamental
- Price
- RNAZ $8.60
- YCBD $0.70
- Analyst Decision
- RNAZ Strong Buy
- YCBD Strong Buy
- Analyst Count
- RNAZ 1
- YCBD 1
- Target Price
- RNAZ $280.00
- YCBD $2.00
- AVG Volume (30 Days)
- RNAZ 19.3K
- YCBD 170.6K
- Earning Date
- RNAZ 11-14-2025
- YCBD 12-17-2025
- Dividend Yield
- RNAZ N/A
- YCBD N/A
- EPS Growth
- RNAZ N/A
- YCBD N/A
- EPS
- RNAZ N/A
- YCBD N/A
- Revenue
- RNAZ N/A
- YCBD $19,026,064.00
- Revenue This Year
- RNAZ N/A
- YCBD $0.37
- Revenue Next Year
- RNAZ N/A
- YCBD $4.95
- P/E Ratio
- RNAZ N/A
- YCBD N/A
- Revenue Growth
- RNAZ N/A
- YCBD N/A
- 52 Week Low
- RNAZ $6.15
- YCBD $0.59
- 52 Week High
- RNAZ $468.44
- YCBD $6.54
- Technical
- Relative Strength Index (RSI)
- RNAZ 34.45
- YCBD 31.86
- Support Level
- RNAZ $8.41
- YCBD $0.76
- Resistance Level
- RNAZ $9.85
- YCBD $0.83
- Average True Range (ATR)
- RNAZ 0.68
- YCBD 0.06
- MACD
- RNAZ -0.30
- YCBD -0.02
- Stochastic Oscillator
- RNAZ 11.05
- YCBD 4.98
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.